Detalles de la búsqueda
1.
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop).
Eur J Neurol
; 31(6): e16250, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38549186
2.
Cost and effectiveness of autologous haematopoietic stem cell transplantation and high-efficacy disease-modifying therapies in relapsing-remitting multiple sclerosis.
Neurol Sci
; 45(7): 3379-3387, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38277051
3.
Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantation.
Eur J Neurol
; 30(10): 3362-3366, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37483174
4.
The contribute of cerebrospinal fluid free light-chain assay in the diagnosis of multiple sclerosis and other neurological diseases in an Italian multicenter study.
Mult Scler
; 28(9): 1364-1372, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34965771
5.
Autologous haematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis.
Eur J Neurol
; 29(6): 1708-1718, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35146841
6.
Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis.
Mult Scler
; 27(1): 61-70, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32008439
7.
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.
Mult Scler
; 26(12): 1519-1531, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31573386
8.
Association of celiac disease in patients with multiple sclerosis in Tuscany.
Rev Esp Enferm Dig
; 112(6): 474-476, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32379467
9.
Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies.
Ann Neurol
; 83(2): 283-294, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29328521
10.
Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance.
Neurol Sci
; 43(7): 4095-4097, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35318561
11.
Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis.
J Neuroinflammation
; 12: 132, 2015 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-26169064
12.
Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy.
J Neurovirol
; 21(6): 666-70, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25678142
13.
Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantation.
Front Neurol
; 15: 1373385, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38899059
14.
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis.
J Neurol
; 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38568227
15.
Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience.
Mult Scler Relat Disord
; 72: 104582, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36889098
16.
Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis.
Neurology
; 100(11): e1109-e1122, 2023 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36543569
17.
Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: A population-based study on Tuscan residents.
Mult Scler Relat Disord
; 60: 103679, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35217486
18.
Effect of disease-modifying treatments on antibody-mediated response to anti-COVID19 vaccination in people with multiple sclerosis.
J Neurol
; 269(6): 2840-2847, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35239006
19.
Case report: A multiple sclerosis patient with imaging features of glymphatic failure benefitted from CSF flow shunting.
Front Neurosci
; 16: 863117, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36389221
20.
Investigating Serum sHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple Sclerosis.
Front Neurol
; 13: 872396, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35693002